Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study of Regorafenib with BRAF/MEK-Inhibitor Combination for Patients with Advanced Melanoma After Previous Treatment
Recruiting
Investigated Diseases:Investigated Drugs:
Phase Ib/II study of momelotinib with nivolumab or pembrolizumab in unresectable stage III/IV cutaneous melanoma
Not yet recruiting
Investigated Diseases:Investigated Drugs:
A study of ipilimumab and nivolumab to observe immune system changes in patients with unresectable stage III or IV melanoma
Not yet recruiting
Investigated Diseases:Investigated Drugs:
Study of BNT111 and cemiplimab in patients with advanced melanoma who have not responded to other therapies
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of local treatment options for large metastases in patients with BRAF V600 mutated melanoma receiving Encorafenib and Binimetinib combination therapy
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery
Not recruiting
Investigated Diseases:Investigated Drugs:
+7
Study of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on the Safety and Effects of ATL001 and Nivolumab for Adults with Metastatic or Recurrent Melanoma
Not recruiting
Investigated Diseases:
Study on the Effectiveness and Safety of RO7198457 and Pembrolizumab for Patients with Untreated Advanced Melanoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation
Not recruiting
Investigated Diseases:Investigated Drugs:
+5